XML 32 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
OPERATING ACTIVITIES:      
Comprehensive loss $ (76,173) $ (42,304) $ (38,820)
Adjustments in respect of income and expenses not involving cash flow:      
Share-based compensation to employees and service providers 4,202 3,027 2,678
Depreciation 1,710 997 90
Amortization and impairment of intangible assets 7,035 216  
Non-cash interest expenses related to borrowing and payable in respect of intangible assets purchase and royalty obligation 6,032    
Fair value adjustments on derivative financial instruments   (344) (104)
Fair value losses (gains) on financial assets at fair value through profit or loss 94 (27) 137
Exchange differences and revaluation of bank deposits 101 24 138
Total adjustments in respect of income and expenses not involving cash flow 19,174 3,893 2,939
Changes in assets and liability items:      
Decrease (increase) in trade receivables (27,439) (258) 570
Decrease (increase) in prepaid expenses and other receivables (3,277) (368) 1,414
Increase in inventories (4,644) (1,113) (116)
Increase (decrease) in accounts payable 7,369 860 (1,481)
Increase (decrease) in accrued expenses and other liabilities 19,335 (2,726) 722
Increase in allowance for deductions from revenue 17,076 1,267 310
Total changes in assets and liability items 8,420 (2,338) 1,419
Net cash used in operating activities (48,579) (40,749) (34,462)
INVESTING ACTIVITIES:      
Purchase of fixed assets (406) (168) (23)
Purchase of intangible assets (53,368) (35) (35)
Change in investment in current bank deposits 10,200 (2,069) 4,869
Purchase of financial assets at fair value through profit or loss   (4,325) (6,976)
Proceeds from sale of financial assets at fair value through profit or loss 7,925 11,761 7,517
Net cash provided by (used in) investing activities (35,649) 5,164 5,352
FINANCING ACTIVITIES:      
Proceeds from issuance of ordinary shares, net of issuance costs 23,867 36,300 41,902
Exercise of options into ordinary shares 52 5 361
Proceeds from long-term borrowing, net of transaction costs 78,061    
Increase in restricted cash (20,000)    
Decrease in restricted cash 4,000    
Payment of principal with respect to lease liabilities (1,610) (796)  
Repayment of payable in respect of intangible asset purchase     (500)
Net cash provided by financing activities 84,370 35,509 41,763
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 142 (76) 12,653
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS 130 94 (103)
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 29,023 29,005 16,455
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF PERIOD 29,295 29,023 29,005
SUPPLEMENTARY INFORMATION ON INTEREST RECEIVED IN CASH 414 753 $ 728
SUPPLEMENTARY INFORMATION ON INTEREST PAID IN CASH 6,654 251  
Acquisition of right-of-use assets by means of lease liabilities 2,930 2,805  
Purchase of intangible assets posted as payable 24,619    
Purchase of an intangible asset in consideration for issuance of shares $ 1,914 $ 11,788